Michel Gallant,Jean-Francois Truchon,Thumkunta Jagadeeswar Reddy,Evelyne Dietrich,Louis Vaillancourt,Frederic Vallee
申请号：
US15735412
公开号：
US20180244658A1
申请日:
2016.06.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The compounds represented by Formula (I) or pharmaceutically acceptable salts thereof: with U, W, X, Y, Z, p and ring A as defined in claim 1. Those compounds are useful for the treatment or prevention of bacteria infections. The variables of Formula (I) are as described herein. Pharmaceutically acceptable compositions comprise the compounds of Formula (I) or pharmaceutically acceptable salts thereof and pharmaceutically acceptable carriers, adjuvants, or vehicles. Methods of treating bacteria infections employ such compounds or pharmaceutically acceptable salts thereof.
